Nail Abnormalities

Jeffrey C. Leggit, MD

American Family Physician. 2025;112(4):401-409.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Nail abnormalities occur in all age groups but are more prevalent in older adults. Nail disorders account for 10% of dermatologic disorders. Nail abnormalities can be categorized as surface texture irregularities, color changes, defects of nail plate attachment/nail shedding, tumors, or a combination of these. Brittle nails affect up to 20% of the population but are most prominent in older women and on fingernails. Different patterns of brittle nails can be seen in the same patient or can coexist in the same nail. Beau lines are transverse grooves caused by decreased keratinocyte activity in the proximal nail matrix. Nail pitting is due to abnormal keratinization in the proximal nail matrix. More than one-half of patients with psoriasis will have some nail involvement, and pitted nails are just one manifestation of nail psoriasis. Color changes may appear in the nail plate, nail bed, or nail matrix. In the nail unit, melanocytes are located only in the nail matrix. Brown-black nail changes are known as melanonychia and are caused by melanocyte activation or proliferation. Melanoma typically presents as longitudinal brown-black nail lines, but in approximately 30% of cases, it may present as a nail mass. Abnormal growth in the nail unit should raise concern for benign or malignant tumors, including the most common malignant tumor, squamous cell carcinoma. Nail clippings, ultrasonography, dermoscopy, and biopsy are useful for the diagnosis of nail abnormalities. Dermoscopy can assist in triaging lesions and differentiating those that can be safely observed from those that should be biopsied.

JEFFREY C. LEGGIT, MD, CAQSM, is a professor in the Department of Family Medicine at the Uniformed Services University of the Health Sciences, Bethesda, Maryland.

Address correspondence to Jeffrey C. Leggit, MD, CAQSM, at jeff.leggit@usuhs.edu.

Author disclosure: No relevant financial relationships.

  1. 1.Dhingra G, Ahmad N, Tanwar S, et al. Nail disorders: an updated review. Int J Pharm Sci Rev Res. 2022;75(2):135-144.
  2. 2.Singh G, Haneef NS, Uday A. Nail changes and disorders among the elderly. Indian J Dermatol Venereol Leprol. 2005;71(6):386-392.
  3. 3.Muddasani S, Lin G, Hooper J, et al. Nutrition and nail disease. Clin Dermatol. 2021;39(5):819-828.
  4. 4.Frazier WT, Santiago-Delgado ZM, Stupka KC. Onychomycosis: rapid evidence review. Am Fam Physician. 2021;104(4):359-367.
  5. 5.Wollina U, Nenoff P, Haroske G, et al. The diagnosis and treatment of nail disorders. Dtsch Arztebl Int. 2016;113(29–30):509-518.
  6. 6.Tully AS, Trayes KP, Studdiford JS. Evaluation of nail abnormalities. Am Fam Physician. 2012;85(8):779-787.
  7. 7.Richert B, Caucanas M, André J. Diagnosis using nail matrix. Dermatol Clin. 2015;33(2):243-255.
  8. 8.Lee DK, Lipner SR. Optimal diagnosis and management of common nail disorders. Ann Med. 2022;54(1):694-712.
  9. 9.Daniel CR III. An approach to initial examination of the nail. In: Scher RK, Daniel CR III, eds. Nails: Diagnosis, Therapy, Surgery. Elsevier Saunders; 2005: 97.
  10. 10.Bloom A, Blanken B, Schlakman B, et al. A review of nail dystrophies for the practitioner. Adv Skin Wound Care. 2020;33(1):20-26.
  11. 11.Leggit JC. Acute and chronic paronychia. Am Fam Physician. 2017;96(1):44-51.
  12. 12.Brosche T, Dressler S, Platt D. Age-associated changes in integral cholesterol and cholesterol sulfate concentrations in human scalp hair and finger nail clippings. Aging (Milano). 2001;13(2):131-138.
  13. 13.Chessa MA, Iorizzo M, Richert B, et al. Pathogenesis, clinical signs and treatment recommendations in brittle nails: a review. Dermatol Ther (Heidelb). 2020;10(1):15-27.
  14. 14.van de Kerkhof PCM, Pasch MC, Scher RK, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005;53(4):644-651.
  15. 15.Iorizzo M. Tips to treat the 5 most common nail disorders: brittle nails, onycholysis, paronychia, psoriasis, onychomycosis. Dermatol Clin. 2015;33(2):175-183.
  16. 16.Braswell MA, Daniel CR, Brodell RT. Beau lines, onychomadesis, and retronychia: a unifying hypothesis. J Am Acad Dermatol. 2015;73(5):849-855.
  17. 17.Ko D, Lipner SR. Concurrent beau lines, onychomadesis, and retronychia following scurvy. Cutis. 2020;105(3):146-147.
  18. 18.Piraccini BM, Alessandrini A. Drug-related nail disease. Clin Dermatol. 2013;31(5):618-626.
  19. 19.Kyriakou A, Patsatsi A, Sotiriadis D. Biologic agents in nail psoriasis: efficacy data and considerations. Expert Opin Biol Ther. 2013;13(12):1707-1714.
  20. 20.Fawcett RS, Linford S, Stulberg DL. Nail abnormalities: clues to systemic disease. Am Fam Physician. 2004;69(6):1417-1424.
  21. 21.Lipner SR, Scher RK. Evaluation of nail lines: color and shape hold clues. Cleve Clin J Med. 2016;83(5):385-391.
  22. 22.Tosti A, Piraccini BM, de Farias DC. Dealing with melanonychia. Semin Cutan Med Surg. 2009;28(1):49-54.
  23. 23.Ruben BS. Pigmented lesions of the nail unit: clinical and histopathologic features. Semin Cutan Med Surg. 2010;29(3):148-158.
  24. 24.Piraccini BM, Dika E, Fanti PA. Tips for diagnosis and treatment of nail pigmentation with practical algorithm. Dermatol Clin. 2015;33(2):185-195.
  25. 25.Mannava KA, Mannava S, Koman LA, et al. Longitudinal melanonychia: detection and management of nail melanoma. Hand Surg. 2013;18(1):133-139.
  26. 26.Littleton TW, Murray PM, Baratz ME. Subungual melanoma. Orthop Clin North Am. 2019;50(3):357-366.
  27. 27.Metin MS, Elmas ÖF. Dermoscopic diagnosis of subungual hematoma: new observations. Postepy Dermatol Alergol. 2020;37(4):490-494.
  28. 28.Cao Y, Han D. Longitudinal melanonychia: how to distinguish a malignant condition from a benign one. Chin J Plast Reconstr Surg. 2021;3(1):56-62.
  29. 29.Hamad MN, Ravella KC, Lipman MD, et al. Local and systemic nail plate abnormalities: a clinical review. J Hand Surg Am. 2023;48(9):931-940.
  30. 30.Baran R, de Berker D, Holzberg M, et al. Koilonychia. In: Baran R, de Berker DAR, Holzberg M, et al., eds. Baran and Dawber’s Diseases of the Nails and Their Management. 5th ed. Wiley Blackwell; 2019.
  31. 31.Baran R, Perrin C, Baudet J, et al. Clinical and histological patterns of dermatofibromas of the nail apparatus. Clin Exp Dermatol. 1994;19(1):31-35.
  32. 32.Vogl A, Hoffman C, Shenouda E. Painful finger lesion. Am Fam Physician. 2024;110(6):637-638.
  33. 33.Bhaskaranand K, Navadgi BC. Glomus tumour of the hand. J Hand Surg [Br]. 2002;27(3):229-231.
  34. 34.Jellinek NJ, Lipner SR. Longitudinal erythronychia: retrospective single-center study evaluating differential diagnosis and the likelihood of malignancy. Dermatol Surg. 2016;42(3):310-319.
  35. 35.Dalle S, Depape L, Phan A, et al. Squamous cell carcinoma of the nail apparatus: clinicopathological study of 35 cases. Br J Dermatol. 2007;156(5):871-874.
  36. 36.Thai KE, Young R, Sinclair RD. Nail apparatus melanoma. Australas J Dermatol. 2001;42(2):71-81.
  37. 37.Stephen S, Tosti A, Rubin AI. Diagnostic applications of nail clippings. Dermatol Clin. 2015;33(2):289-301.
  38. 38.Wortsman X, Wortsman J, Guerrero R, et al. Anatomical changes in retronychia and onychomadesis detected using ultrasound. Dermatol Surg. 2010;36(10):1615-1620.
  39. 39.Alessandrini A, Starace M, Piraccini BM. Dermoscopy in the evaluation of nail disorders. Skin Appendage Disord. 2017;3(2):70-82.
  40. 40.Haenssle HA, Blum A, Hofmann-Wellenhof R, et al. When all you have is a dermatoscope—start looking at the nails. Dermatol Pract Concept. 2014;4(4):11-20.
  41. 41.Tosti A, Argenziano G. Dermoscopy allows better management of nail pigmentation. Arch Dermatol. 2002;138(10):1369-1370.
  42. 42.Grover C, Bansal S. Nail biopsy: a user’s manual. Indian Dermatol Online J. 2018;9(1):3-15.
  43. 43.Domínguez-Cherit J, Gutiérrez Mendoza D. Best way to perform a punch biopsy. Dermatol Clin. 2015;33(2):273-276.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.